Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) SHH

58.27

+0.32(+0.55%)

Updated at December 25 03:00PM

Currency In CNY

Valuation

Market Cap5.28B
Enterprise Value4.42B
P/E Ratio42.09
PEG Ratio6.84
Price/Sales Ratio7.72
Price/Book Ratio3.54
Enterprise/Revenue7.41
Enterprise/EBITDA43.89

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.18
Operating Margin0.18

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue1.35B
Revenue/Share7.62
Gross Profit1B
EBITDA249.79M
Net Income238.23M
Diluted EPS1.36

Balance Sheet

Total Cash1.57B
Total Cash/Share8.98
Total Debt172.06M
Total Debt/Equity0.06
Current Ratio3.5
Book Value Per Share16.44

Price History

52-Week Change89.87
52-Week High73.66
52-Week Low28.85
Moving Average 50 Days55.22
Moving Average 200 Days48.59

Statistics

Average Volume1.68M
Shares Outstanding176M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.43
Trailing Annual Dividend Yield0.74
Payout Ratio0.32
Last Split Factor147:100
Last Split DateJuly 01, 2024